Figure 3.
Mean surface dose (with standard deviation) measured without and with bolus application at six locations around the scar region against each patient during the course of conventional treatment in (a) Group A of postmastectomy radiotherapy patients (n = 28), (b) Group B of postmastectomy radiotherapy patients (n = 28), and (c) Group C of postmastectomy radiotherapy patients (n = 26)